Award
Delivery Order #SPE2DR26FMKL0
Short-Term Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FMKL0
NAICS
424210
This is a brief delivery order contract awarded to DMS Pharmaceutical Group Inc., a pharmaceutical services provider, for the procurement of Midazolam Hydrochloride, a critical pharmaceutical product. The award follows under an existing indefinite delivery vehicle (IDV) contract, emphasizing continuity and reliability in pharmaceutical supplies. The contract covers the delivery of Midazolam Hydrochloride within a concise timeframe at a single location in Park Ridge, Illinois. While the specific procurement approach for this delivery order is not detailed, it operates within an established competitive IDV framework, reinforcing adherence to fair bidding practices. The contract's timeframe is notably short-term, highlighting an immediate supply need. This award strengthens the agency's pharmaceutical acquisition capabilities, ensuring essential medications are available for healthcare operations.
Description
4571171684! MIDAZOLAM HYDROCHLORI